Strain Name: |
B6.Cg-Tg(CAG-Ub*G76V/GFP)2Dant/J |
|---|---|
Stock Number: |
008112 |
Availability: | Under Development for Distribution Colony |
| To register your interest in this strain go to the Strain Interest Form. |
General Terms and Conditions |
| Former Name |
B6.Cg-Tg(ACTB-Ub*G76V/GFP)2Dant/J (Changed: 08-MAY-08
) |
| Genes & Alleles | ACTB; GFP; Tg(CAG-Ub*G76V/GFP)2Dant; |
Type JAX® GEMM® Strain - Mutant Strain Additional information on JAX® GEMM® Strains. Type JAX® GEMM® Strain - Transgenic Mating System Noncarrier x Hemizygote (Female x Male) Species laboratory mouse Donating Investigator Nico Dantuma, Karolinska Institutet Generation N31+ (21-JUL-08) Strain Description
Hemizygous transgenic mice are viable and fertile; they contain the green fluorescent protein (GFP) fused to a constitutively active degradation signal (UbG76V). Transgenic transcripts are detected in all tissues examined; however no GFP protein expression is detected due to the G76V substitution which leads to its ubiquitination and proteasomal degradation. Following administration of proteasome inhibitors, UbG76V accumulates and GFP-derived fluorescence is readily apparent, evidence of an impaired ubiquitin/proteasome system. This strain and UbG76V-GFP/1 (Stock No. 008111) have similar expression patterns, but this line (UbG76V-GFP/2) shows lower transgene expression and is not reported to display background fluorescence. These strains may be useful for monitoring ubiquitin/proteasome-dependent proteolysis in diverse disorders, and in efficacy trials for monitoring the effect of compounds on the ubiquitin/proteasome system (for example, in tests with proteasome inhibitors as novel anticancer drugs).Strain Development
The UbG76V-GFP transgene was designed with a chicken beta-actin promoter (and cytomegalovirus (CMV) immediate early enhancer) upstream of a green fluorescent protein (GFP) fused to a mutant ubiquitin moiety (UbG76V), a constitutively active proteasome degradation signal. The transgene was microinjected into the pronucleus of fertilized (CBAxC57BL/6)F1 oocytes, and the transgenic offspring e bred to C57BL/6N. Founder line 2 (UbG76V-GFP/2) mice, with lower expression of the transgene than line 1, were backcrossed to C57BL/6N for approximately 30 generations prior to arrival at The Jackson Laboratory. Upon arrival, mice were bred with C57BL/6NJ (Stock No. 005304) to establish the colony.
Mammalian Phenotype Terms assigned by genotype |
| Allele Symbol | Tg(CAG-Ub*G76V/GFP)2Dant | ||
|---|---|---|---|
| Allele Name | transgene insertion 2, Nico Dantuma | ||
| Common Name(s) | Tg(ACTB-Ub*G76V/GFP)2Dant; Tg(CAG-Ub*G76V/GFP)2Dant; UPS reporter; UbG76V-GFP/2; UbG76V-GFP/2; | ||
| Mutation Made By | Nico Dantuma, Karolinska Institutet | ||
| Strain of Origin | (CBA x C57BL/6)F1 | ||
| Site of Expression | Transgene transcripts are detected in all tissues examined; however the G76V substitution leads to degradation, of the GFP. Following administration of proteasome inhibitors, UbG76V accumulates and GFP-derived fluorescence is apparent. This line shows lower transgene expression and is not reported to display background fluorescence. | ||
| Expressed Gene | GFP, Green Fluorescent Protein, jellyfish | ||
| Green Fluorescent Protein (GFP), derived from the jellyfish Aequorea victoria, is a versatile reporter molecule which has found use in many biological applications. In some constructs the original molecule has been modified in order to enhance its fluorescence intensity (EGFP, enhanced GFP). When utilized in a transgenic construct, tissue expressing sufficient amounts of GFP will fluoresce when exposed to a 488 nm light source. | |||
| Promoter | ACTB, actin, beta, chicken | ||
| Molecular Note | The UbG76V-GFP transgene was designed with a chicken beta-actin promoter (and cytomegalovirus (CMV) immediate early enhancer) upstream of a green fluorescent protein (GFP) fused to a mutant ubiquitin moiety (UbG76V). This transgene was microinjected into the pronucleus of fertilized (CBA x C57BL/6)F1 oocytes. Although transcripts of the UbG76V-GFP fusion gene are detected in all tissues examined, the G76V substitution prevents removal of the ubiquitin moiety leading to efficient ubiquitination and proteasomal degradation of the fusion protein (and thus no fluorescence) in these tissues. Line 2 with low expression was maintained by backcross to C57BL/6N mice. [MGI Ref ID J:127085] [MGI Ref ID J:127087] | ||
| Control | ||
|---|---|---|
| Noncarrier | ||
| 005304 C57BL/6NJ | ||
| Considerations for Choosing Controls | ||
Tg(CAG-Ub*G76V/GFP)1Dant, Tg(CAG-Ub*G76V/GFP)2Dant
| Breeding & Husbandry | When maintaining a live colony, hemizygotes may be bred to wildtype siblings or to C57BL/6NJ (Stock No. 005304) inbred mice. |
|---|---|
| Diet Information | LabDiet® 5K52/5K67 |
Strains carrying other alleles of ACTB
View Strains carrying other alleles of ACTB (31 strains)
Strains carrying other alleles of GFP
View Strains carrying other alleles of GFP (84 strains)
Congenic Nomenclature
Fluorescent Proteins/lacZ Systems
GFP relatedCancer Research
Other
Cell Biology Research
Post-translational Processing
Protein Processing (degradation)
Neurobiology Research
Fluorescent protein expression in neural tissue
Research Tools
Cancer Research
Cell Biology Research
Fluorescent Proteins
Toxicology Research (drug/compound testing)
Research Tools
Fluorescent Proteins
Selected Reference(s)
Additional ReferencesBowman AB; Yoo SY; Dantuma NP; Zoghbi HY. 2005. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum Mol Genet 14(5):679-91. [PubMed: 15661755] [MGI Ref ID J:96393]
Lindsten K; Menendez-Benito V; Masucci MG; Dantuma NP. 2003. A transgenic mouse model of the ubiquitin/proteasome system. Nat Biotechnol 21(8):897-902. [PubMed: 12872133] [MGI Ref ID J:127085]
| Strain Name: | B6.Cg-Tg(CAG-Ub*G76V/GFP)2Dant/J |
| Stock Number: | 008112 |
This strain is currently Under Development for Distribution Colony.
To register your interest in this strain go to the Strain Interest Form.
Estimated Available for Sale Date: 06-OCT-08
Please note: Estimated available for sale dates are provided to keep customers better informed on strains under development. Please note that our Colony Managers routinely monitor the target date and edit it based on breeding performance and other factors. The length of time it takes to make a new strain available for sale depends on genotype, age, number of animals sent by the Donating Investigator, breeding performance, additional strain development (backcrossing, making homozygous), and anticipated demand for the strain/interest registered.
View All Strains Under Development
| Standard Supply | Under Development for Distribution Colony |
|---|---|
| Supply Notes |
This strain is included in the Induced Mutant Resource Colony collection. |
| Licensing | See General Terms and Conditions below for Licensing and Use Restrictions |
| Control Information | View Control Information in Strain Details. |
For additional Licensing and Use Restrictions view the link(s) below:
- Strain(s) not available to companies or for-profit entities.
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form